Chiara Troncatti, currently working at Amylyx Pharmaceuticals as Head of Business Strategy and Operations and previously held positions at various companies such as Qral Group, Akcea Therapeutics, and Boehringer Ingelheim. With extensive experience in commercial operations, market analysis, forecasting, and business intelligence, Chiara has a diverse background in strategic planning and project management within the pharmaceutical industry. Chiara holds a Bachelor's degree in Economics and Political Science from Alma Mater Studiorum – Università di Bologna, as well as Master's degrees in Business and Economics from Uppsala University and International Management from ICN Business School.
October 1, 2023 - present
January, 2022